Peptide Lexicon

5-amino-1MQ

5-amino-1MQ in the T&T Supplies peptide lexicon: research reference with mechanism, reported effects, limitations and literature data. Evidence grade C.

Mechanism

Small molecule that inhibits CD38, the primary NAD+-degrading enzyme in the body. Inhibits CD38 (NAD+ glycohydrolase) → NAD+ levels rise. CD38 activity increases dramatically with age and inflammation.

Reported effects

NAD+ preservation. Potential fat loss effects (adipocyte CD38 inhibition). Anti-inflammatory. More targeted mechanism than NMN/NR for NAD+ elevation.

Limitations

Very limited human data. Research peptide status. Long-term safety unknown.

Literature data

Dosage (literature)

5-50mg oral or 1-5mg subcut

Timing

Morning

Cycling

4-8 week cycles

Information for research purposes only.